← All trials
NCT02280057
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2001
- Primary completion
- Dec 1, 2002
- Completion date
- Dec 1, 2002
- First posted
- —
- Last posted
- —
- Enrollment
- 56
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Herning HospitalLead sponsor
- Herning HospitalReponsible party - principal investigator
- GEA A/S DenmarkCollaborator
- Herning HospitalOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.